heart failureischemic heart diseaseoutcomesThe primary aim of the current study was to investigate global differences in prevalence, association with outcome, and treatment of ischemic heart disease (IHD) in patients with acute heart failure (AHF) in the REPORT-HF (International Registry to Assess...
3) Ischemia heart disease 缺血性心脏病 1. Objective To study mechanism of treating Ischemia heart disease with Xinnaotongluoye. 目的探讨心脑通络液治疗缺血性心脏病的机理。 2. Objective To investigate the therapeutic effect of Qiguiyimailing for treatment of premature ventricular beat in patients ...
BRILINTA® (ticagrelor) is an oral prescription indicated for treatment of acute ischemic stroke, coronary artery disease and acute coronary syndrome.
April 30, 2024 — A multicenter study led by Vanderbilt University Medical Center (VUMC) and Lipscomb University College of Pharmacy in Nashville has identified a potential new treatment for acute heart failure, a leading cause of hospitalization and death. The drug, dapagliflozin, was initially app...
treatment of acute ischemic stroke during the first 24 hours after symptom onset has not been investigated. Because heparin, aspirin, or Activase may cause bleeding complications, carefully monitor for bleeding, especially at arterial puncture sites. Hemorrhage can occur 1 or more days after ...
Dedicated “intestinal stroke centers” have highlighted the effectiveness of a multidisciplinary approach focusing on: (1) removal of non-viable ischemic bowel, (2) preservation of intestine with revascularization, and (3) intensive care treatment to prevent progression to multiorgan failure. Utilizing...
Gender differences in survival in advanced heart failure. Insights from the FIRST study Circulation, 99 (1999), pp. 1816-1821 Google Scholar 26 E. Cenko, M. van der Schaar, J. Yoon, et al. Sex-specific treatment effects after primary percutaneous intervention: a study on coronary blood flo...
Although no treatment was given to maintain hemodynamic stability, echocardiography revealed normal left ventricular contraction 14 days after the onset of the ventricular dysfunction. The reversible ventricular dysfunction might have been induced by altered catecholamine dynamics due to the persistent syncope...
treatment of acute ischemic stroke during the first 24 hours after symptom onset has not been investigated. Because heparin, aspirin, or Activase may cause bleeding complications, carefully monitor for bleeding, especially at arterial puncture sites. Hemorrhage can occur 1 or more days after ...
Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke. 2009;40(8):2945-2948. doi:10.1161/STROKEAHA.109.192535PubMedGoogle ScholarCrossref 18. Jauch ...